Evidence map›Paper›PMID 32414396›Full record

ArticleParasites & vectors2020

Lufenuron can be transferred by gravid Aedes aegypti females to breeding sites and can affect their fertility, fecundity and blood intake capacity.

Paula V Gonzalez, Laura Harburguer

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Paula V GonzalezCentro de Investigaciones de Plagas e Insecticidas (CIPEIN-UNIDEF/CITEDEF/CONICET), J.B. de La Salle 4397, Villa Martelli (1603), Buenos Aires, Argentina.
Laura HarburguerCentro de Investigaciones de Plagas e Insecticidas (CIPEIN-UNIDEF/CITEDEF/CONICET), J.B. de La Salle 4397, Villa Martelli (1603), Buenos Aires, Argentina. lharburguer@citedef.gob.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARInstitute of Scientific and Technical Research for Defense · AR

Funding

Fondo para la Investigación Científica y Tecnológica 2015-1729
6 · The paper itself

Abstract

backgroundAedes aegypti (L.) is the main vector of dengue, yellow fever, Zika and chikungunya viruses. A new method for controlling this mosquito has been developed based on the possibility that wild adult mosquitoes exposed to artificial resting sites contaminated with a larvicide, can disseminate it to larval breeding sites, is named "auto-dissemination". The present study was undertaken to evaluate if a chitin synthesis inhibitor like lufenuron can be disseminated to larval breeding sites and prevent adult emergence and also if forced contact of Ae. aegypti females with treated surfaces can affect its fertility, fecundity, and blood intake capacity.

methodsLarval susceptibility to lufenuron was measured through EI

resultsLufenuron proved to be very active against Ae. aegypti larvae with an EI

conclusionsThis study introduces an innovation by first exploring the possibility that an insect growth regulator (IGR) belonging to the group of benzoylphenyl ureas, such as lufenuron, can be transferred by gravid females to breeding sites and that at the same time can have an effect on fertility, fecundity and blood intake capacity of adult mosquitoes.

Indexed as

BenzamidesBreedingFeeding BehaviorInsecticidesAedesAnimalsBloodFemaleFertilityFluorocarbonsGravidityLarvaMosquito ControlMosquito VectorsBenzamidesFluorocarbonsfluphenacurInsecticidesAedes aegyptiAuto-diseminationFecundityFertilityLufenuron

Identifiers

PMID32414396
PMCPMC7227266
OpenAlexW3027411751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.